Health & Personal Care
MEDIUM
FDA DRUG
Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
DESMOPRESSIN ACETATE
Defective container: